Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.40% |
AMGEN INC. | AMGN | 5.01% |
GILEAD SCIENCES, INC. | GILD | 4.66% |
VERTEX PHARMACEUTICALS | VRTX | 4.47% |
REGENERON PHARMACEUTICALS | REGN | 3.60% |
CORTEVA INC | CTVA | 3.03% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.75% |
BEIGENE LTD ADR | BGNE | 2.25% |
ASTRAZENECA PLC ADR | AZN | 2.10% |
BIOGEN IDEC, INC. | BIIB | 2.04% |
NATERA INC | NTRA | 2.03% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.75% |
INSMED INC | INSM | 1.71% |
UNITED THERAPEUTICS CORP | UTHR | 1.69% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.68% |
INTRA-CELLULAR T | ITCI | 1.63% |
ILLUMINA INC | ILMN | 1.60% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.53% |
VIATRIS INC | VTRS | 1.43% |
MODERNA INC | MRNA | 1.42% |
EXELIXIS, INC. | EXEL | 1.40% |
EXACT SCIENCES | EXAS | 1.37% |
VAXCYTE INC | PCVX | 1.31% |
INCYTE CORP | INCY | 1.30% |
ARGENX SE - ADR | ARGX | 1.29% |
HALOZYME THERAPEUTICS INC | HALO | 1.29% |
ALKERMES PLC | ALKS | 1.17% |
BRIDGEBIO PHARMA INC | BBIO | 1.16% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.16% |
GUARDANT HEALTH INC | GH | 1.14% |
REVOLUTION MEDICINES INC | RVMD | 1.14% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.11% |
BIONTECH SE-ADR | BNTX | 1.10% |
TG THERAPEUTICS | TGTX | 1.09% |
BLUEPRINT MEDICI | BPMC | 1.08% |
CYTOKINETICS INC | CYTK | 1.00% |
MEDPACE HOLDINGS | MEDP | 1.00% |
SAREPTA THERAPEU | SRPT | 0.99% |
ADMA BIOLOGICS INC | ADMA | 0.99% |
IONIS PHARMACEUTICALS, IN | IONS | 0.97% |
CRISPR THERAPEUTICS AG | CRSP | 0.96% |
ROIVANT SCIENCES LTD | ROIV | 0.95% |
AXSOME THERAPEUT | AXSM | 0.94% |
PTC THERAPEUTICS | PTCT | 0.85% |
AVIDITY BIOSCIENCES INC | RNA | 0.83% |
ULTRAGENYX PHARM | RARE | 0.82% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.81% |
CRINETICS PHARMACEUTICALS | CRNX | 0.79% |
PROTAGONIST THER | PTGX | 0.73% |
APELLIS PHARMACE | APLS | 0.72% |
AMICUS THERAPEUTICS INC | FOLD | 0.71% |
VERACYTE INC | VCYT | 0.70% |
VIKING THERAPEUTICS INC | VKTX | 0.70% |
ARCELLX INC | ACLX | 0.69% |
SUMMIT THERAPEUTICS INC | SMMT | 0.69% |
RECURSION PHARMACEUTICALS | RXRX | 0.68% |
TWIST BIOSCIENCE CORP | TWST | 0.67% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.66% |
BEAM THERAPEUTICS INC | BEAM | 0.63% |
ASCENDIS PHA-ADR | ASND | 0.62% |
DYNAVAX TECHNOLOGY | DVAX | 0.58% |
DENALI THERAPEUT | DNLI | 0.58% |
NUVALENT INC-A | NUVL | 0.57% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.57% |
AGIOS PHARMACEUT | AGIO | 0.57% |
MADRIGAL PHARMAC | MDGL | 0.56% |
IDEAYA BIOSCIENCES INC | IDYA | 0.52% |
KRYSTAL BIOTECH INC | KRYS | 0.51% |
IMMUNOVANT INC | IMVT | 0.51% |
CELLDEX THERAPEUTICS INC | CLDX | 0.49% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.48% |
DYNE THERAPEUTICS INC | DYN | 0.47% |
NOVAVAX INC | NVAX | 0.45% |
INTELLIA THERAPE | NTLA | 0.39% |
GERON CORP | GERN | 0.29% |
Other (Cash, derivatives and other liabilities) | 0.47% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.